Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection ...

Read on to learn about potential common, mild, and serious side effects of methotrexate injections. For a general overview about this drug’s uses and more, refer to this comprehensive ...

A 1-year course of methotrexate may help prevent the development of ACPA-negative RA among patients with clinically suspect arthralgia at high-risk for the disease.

Methotrexate is the most widely used agent for the initial treatment of RA. Studies have shown nonbiologic DMARD combination therapy results in a larger number of responses than methotrexate ...